Stay updated on Pembrolizumab Combo Clinical Trial in Advanced NSCLC
Sign up to get notified when there's something new on the Pembrolizumab Combo Clinical Trial in Advanced NSCLC page.

Latest updates to the Pembrolizumab Combo Clinical Trial in Advanced NSCLC page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.3.3 added; the HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoChange DetectedVersion 76 was posted on 2025-12-10, introducing Contacts/Locations and Study Status to the Record History page. The 2025-12-05 entry was removed.SummaryDifference0.2%

- Check28 days agoChange DetectedA new version entry on 2025-12-05 adds Contacts/Locations and Study Status to the record. This entry corresponds to version 75 posted on 2025-12-03.SummaryDifference0.2%

- Check35 days agoChange DetectedNew entries were added to the record history: Contacts/Locations and Study Status were updated in the 2025-11-26 version, and an item labeled 74 was added in the 2025-11-24 version; an earlier version from 2025-11-10 was removed.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page footer revision label was updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check49 days agoChange DetectedDifference0.3%

Stay in the know with updates to Pembrolizumab Combo Clinical Trial in Advanced NSCLC
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo Clinical Trial in Advanced NSCLC page.